课题基金 / 基金详情

Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA

Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA
TMJ OA 中纤维软骨细胞的细胞基质调节
批准号:
10596064
负责人:
David Andrew Reed
金额:
$41.18万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-01 至 2025-03-31

项目摘要

项目成果

David Andrew Reed的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 TMJ骨关节炎中纤维软骨细胞的细胞基质调节 影响3%-7%人群的颞下颌关节紊乱和骨关节炎(OA) 是与TMJ功能障碍有关的最常见的病理。摘要TMJ骨关节炎是一种软骨疾病。 退变和软骨细胞凋亡。导致软骨细胞凋亡的关键因素之一是 抑制自噬的细胞保护过程。自噬是最早的细胞反应之一 已被证明是延缓软骨进展的一个可行的治疗靶点。 退化。知识上的一个主要差距是机械和炎症应激如何导致最终 抑制自噬、细胞凋亡和软骨退变。为了解决这一差距,我的实验室开发了 临床前手术诱导小鼠TMJ OA模型的专业知识,该模型与人类密切相关 并确定了一个将机械损伤与细胞外基质变化联系起来的三步发病模型 软骨细胞的凋亡,包括1)手术诱导的TMJ后VI型胶原(Col VI)的耗竭 OA2)Col VI软骨细胞受体,神经元/神经胶质抗原2(NG2)的蛋白分解和3)减少 自噬。我们这项研究的总体目标是检验这样一种假设,即损伤导致的VI型胶原退变 激活NG2依赖的途径,通过抑制自噬加速TMJ软骨退化。 根据这份申请中包含的初步数据,我们设计了一项研究计划,以 机械地定义NG2如何与Col VI结合是维持自噬所必需的 激活mTORC1通路。这项拟议的工作具有创新性,因为它专注于一种新的分子 软骨细胞功能与基质功能障碍和细胞保护功能丧失相关的机制 细胞机制参与了TMJ骨关节炎的进展。本研究的意义在于 对TMJ骨关节炎临床问题的潜在应用,代表着我们对TMJ认识的一次飞跃 骨关节炎病理生理学。我们预计,我们的研究结果将为新的治疗方法提供参考 延缓TMJ OA进展并恢复患者TMJ健康的可能性 需要异体全关节置换。
英文摘要
ABSTRACT Cell-matrix regulation of fibrochondrocytes in TMJ OA Disorders of the temporomandibular joint (TMJ) affect between 3-7% of the population and osteoarthritis (OA) is the most common pathology associated with TMJ dysfunction. TMJ OA is a disease of cartilage degeneration and chondrocyte apoptosis. One of the key factors leading to chondrocyte apoptosis is the suppression of the cytoprotective process of autophagy. Autophagy is one of the earliest cellular responses to TMJ OA and has been shown to be a viable therapeutic target for attenuating the progression of cartilage degeneration. A major gap in knowledge is how mechanical and inflammatory stress leads to the eventual suppression of autophagy, apoptosis, and cartilage degeneration. To address this gap, my lab has developed expertise in a preclinical, surgical induction mouse model of TMJ OA that closely corresponds to the human condition and identified a three-step pathogenesis model linking mechanical damage to ECM changes and chondrocyte apoptosis that includes 1) the depletion of Collagen VI (Col VI) following surgically-induced TMJ OA 2) the proteolysis of a Col VI chondrocyte receptor, Neuron/Glial antigen 2 (NG2) and 3) the reduction of autophagy. The overall goal of our study is to test the hypothesis that injury-induced Col VI degeneration activates an NG2-dependent pathway that accelerates TMJ cartilage degeneration by suppressing autophagy. Based on the preliminary data included in this application, we have designed a research plan to mechanistically define how NG2 binding with Col VI is necessary for the maintenance of autophagy through activation of the mTORC1 pathway. The proposed work is innovative because it focuses on a novel molecular mechanism of chondrocyte function that contextually links matrix dysfunction with loss of a cytoprotective cellular mechanism implicated in the progression of TMJ OA. The significance of this research lies in the potential application to the clinical problems of TMJ OA and represents a leap forward in our knowledge of TMJ OA pathophysiology. We anticipate that the outcomes of our study will inform new therapeutic approaches with the potential to attenuate the progression of TMJ OA and restore TMJ health in patients that would otherwise require alloplastic total joint replacement.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA
  • 批准号:
    10209687
  • 项目类别:
  • 资助金额:
    $43.36万
  • 财政年份:
    2021
  • 负责人:
    David Andrew Reed
  • 依托单位:
Cell-Matrix Regulation of Fibrochondrocytes in TMJ OA
  • 批准号:
    10368995
  • 项目类别:
  • 资助金额:
    $41.07万
  • 财政年份:
    2021
  • 负责人:
    David Andrew Reed
  • 依托单位:
Cell-Matrix Regulation of Fibrochondrocytes In TMJ OA
  • 批准号:
    10214992
  • 项目类别:
  • 资助金额:
    $43.29万
  • 财政年份:
    2020
  • 负责人:
    David Andrew Reed
  • 依托单位:
Chondrocyte-pericellular matrix derived signaling maintains tissue integrity in the temporomandibular joint
  • 批准号:
    9762079
  • 项目类别:
  • 资助金额:
    $15.99万
  • 财政年份:
    2018
  • 负责人:
    David Andrew Reed
  • 依托单位:
海外基金